These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
320 related items for PubMed ID: 18022018
21. Clinical spectrum of Anderson Fabry disease in a Romanian family. Tudor A, Muşat A, Doscan A, Bari M, Zapucioiu C, Urdea E, Cochior D, Peţa D. Rom J Intern Med; 2006; 44(2):201-10. PubMed ID: 17236300 [Abstract] [Full Text] [Related]
24. A successful approach for the detection of Fabry patients in Argentina. Rozenfeld PA, Tarabuso A, Ebner R, Ramallo G, Fossati CA. Clin Genet; 2006 Apr; 69(4):344-8. PubMed ID: 16630168 [Abstract] [Full Text] [Related]
32. The molecular defect leading to Fabry disease: structure of human alpha-galactosidase. Garman SC, Garboczi DN. J Mol Biol; 2004 Mar 19; 337(2):319-35. PubMed ID: 15003450 [Abstract] [Full Text] [Related]
33. Transplantation: impact of pretransplant renal insufficiency. Bahirwani R, Campbell MS, Siropaides T, Markmann J, Olthoff K, Shaked A, Bloom RD, Reddy KR. Liver Transpl; 2008 May 19; 14(5):665-71. PubMed ID: 18433034 [Abstract] [Full Text] [Related]
34. Correction of enzymatic and lysosomal storage defects in Fabry mice by adenovirus-mediated gene transfer. Ziegler RJ, Yew NS, Li C, Cherry M, Berthelette P, Romanczuk H, Ioannou YA, Zeidner KM, Desnick RJ, Cheng SH. Hum Gene Ther; 1999 Jul 01; 10(10):1667-82. PubMed ID: 10428212 [Abstract] [Full Text] [Related]
36. [Clinical courses of two male siblings on hemodialysis for Fabry disease ]. Itoh K, Tanaka M, Matsushita K, Miyamura N, Nishida K, Araki E, Nonoguchi H, Tomita K. Nihon Jinzo Gakkai Shi; 2005 Jul 01; 47(2):121-7. PubMed ID: 15859134 [Abstract] [Full Text] [Related]
37. Enzyme replacement therapy for Fabry disease: morphologic and histochemical changes in the urinary sediments. Utsumi K, Mitsuhashi F, Asahi K, Sakurazawa M, Arii K, Komaba Y, Katsumata T, Katsura K, Kase R, Katayama Y. Clin Chim Acta; 2005 Oct 01; 360(1-2):103-7. PubMed ID: 16112661 [Abstract] [Full Text] [Related]
38. Accelerated transport and maturation of lysosomal alpha-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Fan JQ, Ishii S, Asano N, Suzuki Y. Nat Med; 1999 Jan 01; 5(1):112-5. PubMed ID: 9883849 [Abstract] [Full Text] [Related]
39. Remarkable variability in renal disease in a large Slovenian family with Fabry disease. Verovnik F, Benko D, Vujkovac B, Linthorst GE. Eur J Hum Genet; 2004 Aug 01; 12(8):678-81. PubMed ID: 15162124 [Abstract] [Full Text] [Related]